NR546 CEA COMPREHENSIVE EXAM –
ADVANCED PSYCHOPHARMACOLOGY FOR
THE PMHNP – CHAMBERLAIN UNIVERSITY
QUESTIONS AND CORRECT ANSWERS
(VERIFIED ANSWERS) PLUS RATIONALES |
INSTANT DOWNLOAD PDF
Core Domains:
1. Functional Neuroanatomy and Neurotransmitter Systems (15%)
2. Antidepressant and Anxiolytic Pharmacotherapy (20%)
3. Antipsychotic and Mood Stabilizer Pharmacotherapy (20%)
4. Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics
(15%)
5. Special Populations and Clinical Application (15%)
6. Stimulant, Cognitive Enhancer, and Substance Use
Pharmacotherapy (15%)
Introduction
This comprehensive examination is designed to assess the advanced
practice nursing student's mastery of psychopharmacology
principles essential for the Psychiatric-Mental Health Nurse
Practitioner (PMHNP) role. It evaluates the understanding of
neurobiological foundations, pharmacokinetics and
pharmacodynamics, medication selection and monitoring, adverse
effect management, and special population considerations. The
exam utilizes a multiple-choice format with scenario-based
questions that reflect real-world clinical situations and align with
Next Generation NCLEX (NGN) standards. Emphasis is placed on
the application of psychopharmacological concepts to clinical
reasoning, evidence-based prescribing, and patient-centered care.
This assessment serves as a predictor of success on the
Chamberlain University NR546 CEA Comprehensive Exam and
helps identify areas for focused review. The following 100 questions
are organized into six core domains aligned with the official NR546
course competencies and the Examplify online proctored
examination format. Each question includes the correct answer and
, a detailed rationale to enhance clinical reasoning and reinforce
advanced psychopharmacology concepts
.
SECTION ONE: QUESTIONS 1 - 100
DOMAIN 1: FUNCTIONAL NEUROANATOMY AND
NEUROTRANSMITTER SYSTEMS (Questions 1–15)
1. A PMHNP is explaining the mechanism of antipsychotic
medications to a patient. The medication blocks dopamine D2
receptors in the mesolimbic pathway. Which clinical effect is
primarily associated with this action?
A. Reduction of positive symptoms of psychosis
B. Improvement of negative symptoms
C. Extrapyramidal symptoms
D. Prolactin elevation
A. Reduction of positive symptoms of psychosis
RATIONALE: D2 receptor blockade in the mesolimbic pathway
(ventral tegmental area to nucleus accumbens and limbic structures) is
associated with reduction of positive symptoms of psychosis
(hallucinations, delusions). Negative symptoms are primarily associated
with mesocortical dopamine hypofunction. EPS is associated with D2
blockade in the nigrostriatal pathway, and prolactin elevation is
associated with D2 blockade in the tuberoinfundibular pathway.
2. Which brain region is primarily responsible for executive
function, decision-making, and is implicated in the negative
symptoms of schizophrenia?
A. Amygdala
B. Hippocampus
C. Prefrontal cortex
D. Nucleus accumbens
, C. Prefrontal cortex
RATIONALE: The prefrontal cortex (PFC) governs executive function,
working memory, impulse control, and emotional regulation.
Hypofunction of the mesocortical dopamine pathway (VTA → PFC) is
linked to negative symptoms of schizophrenia (avolition, alogia, flat
affect).
3. The amygdala is primarily associated with which function?
A. Executive function and decision-making
B. Fear, anxiety, and emotional processing
C. Memory formation
D. Motor coordination
B. Fear, anxiety, and emotional processing
RATIONALE: The amygdala is a key structure in the limbic system
that processes fear, anxiety, and emotional responses. It is involved in
the formation of emotional memories and the stress response.
Hyperactivity of the amygdala is associated with anxiety disorders.
4. The dorsolateral prefrontal cortex (DLPFC) is primarily
associated with:
A. Higher-level cognitive functioning and executive function
B. Motor inhibition
C. Speech production
D. Emotional processing
A. Higher-level cognitive functioning and executive function
RATIONALE: The dorsolateral prefrontal cortex (DLPFC) is
concerned with higher-level functioning, including working memory,
attention, and executive function. The ventrolateral prefrontal cortex
(VLPFC) is involved with motor inhibition.
5. The orbitofrontal cortex (OFC) is involved in which functions?
A. Decision-making and social behavior with a focus on punishment and
rewards
, B. Speech production and comprehension
C. Motor coordination
D. Fear and anxiety processing
A. Decision-making and social behavior with a focus on punishment
and rewards
RATIONALE: The OFC is involved in decision-making and social
behavior with a focus on punishment and rewards. Behaviors associated
with the OFC include sex, sugar, pain, social humiliation, money,
rewards, fame, and aggression.
6. Which brain region is most consistently associated with reduced
volume and activity in patients with major depressive disorder?
A. Amygdala
B. Prefrontal cortex
C. Hippocampus
D. Basal ganglia
C. Hippocampus
RATIONALE: The hippocampus shows consistent reductions in
volume and activity in major depressive disorder, likely due to chronic
stress-induced neurotoxicity mediated by elevated cortisol levels. This
is associated with memory impairments and cognitive dysfunction in
depression.
7. A current hypothesis for the cause of schizophrenia proposes that
N-methyl-D-aspartate (NMDA) receptors may be which of the
following?
A. Hypofunctional
B. Hyperfunctional
C. Completely absent
D. Overexpressed in the prefrontal cortex
A. Hypofunctional
ADVANCED PSYCHOPHARMACOLOGY FOR
THE PMHNP – CHAMBERLAIN UNIVERSITY
QUESTIONS AND CORRECT ANSWERS
(VERIFIED ANSWERS) PLUS RATIONALES |
INSTANT DOWNLOAD PDF
Core Domains:
1. Functional Neuroanatomy and Neurotransmitter Systems (15%)
2. Antidepressant and Anxiolytic Pharmacotherapy (20%)
3. Antipsychotic and Mood Stabilizer Pharmacotherapy (20%)
4. Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics
(15%)
5. Special Populations and Clinical Application (15%)
6. Stimulant, Cognitive Enhancer, and Substance Use
Pharmacotherapy (15%)
Introduction
This comprehensive examination is designed to assess the advanced
practice nursing student's mastery of psychopharmacology
principles essential for the Psychiatric-Mental Health Nurse
Practitioner (PMHNP) role. It evaluates the understanding of
neurobiological foundations, pharmacokinetics and
pharmacodynamics, medication selection and monitoring, adverse
effect management, and special population considerations. The
exam utilizes a multiple-choice format with scenario-based
questions that reflect real-world clinical situations and align with
Next Generation NCLEX (NGN) standards. Emphasis is placed on
the application of psychopharmacological concepts to clinical
reasoning, evidence-based prescribing, and patient-centered care.
This assessment serves as a predictor of success on the
Chamberlain University NR546 CEA Comprehensive Exam and
helps identify areas for focused review. The following 100 questions
are organized into six core domains aligned with the official NR546
course competencies and the Examplify online proctored
examination format. Each question includes the correct answer and
, a detailed rationale to enhance clinical reasoning and reinforce
advanced psychopharmacology concepts
.
SECTION ONE: QUESTIONS 1 - 100
DOMAIN 1: FUNCTIONAL NEUROANATOMY AND
NEUROTRANSMITTER SYSTEMS (Questions 1–15)
1. A PMHNP is explaining the mechanism of antipsychotic
medications to a patient. The medication blocks dopamine D2
receptors in the mesolimbic pathway. Which clinical effect is
primarily associated with this action?
A. Reduction of positive symptoms of psychosis
B. Improvement of negative symptoms
C. Extrapyramidal symptoms
D. Prolactin elevation
A. Reduction of positive symptoms of psychosis
RATIONALE: D2 receptor blockade in the mesolimbic pathway
(ventral tegmental area to nucleus accumbens and limbic structures) is
associated with reduction of positive symptoms of psychosis
(hallucinations, delusions). Negative symptoms are primarily associated
with mesocortical dopamine hypofunction. EPS is associated with D2
blockade in the nigrostriatal pathway, and prolactin elevation is
associated with D2 blockade in the tuberoinfundibular pathway.
2. Which brain region is primarily responsible for executive
function, decision-making, and is implicated in the negative
symptoms of schizophrenia?
A. Amygdala
B. Hippocampus
C. Prefrontal cortex
D. Nucleus accumbens
, C. Prefrontal cortex
RATIONALE: The prefrontal cortex (PFC) governs executive function,
working memory, impulse control, and emotional regulation.
Hypofunction of the mesocortical dopamine pathway (VTA → PFC) is
linked to negative symptoms of schizophrenia (avolition, alogia, flat
affect).
3. The amygdala is primarily associated with which function?
A. Executive function and decision-making
B. Fear, anxiety, and emotional processing
C. Memory formation
D. Motor coordination
B. Fear, anxiety, and emotional processing
RATIONALE: The amygdala is a key structure in the limbic system
that processes fear, anxiety, and emotional responses. It is involved in
the formation of emotional memories and the stress response.
Hyperactivity of the amygdala is associated with anxiety disorders.
4. The dorsolateral prefrontal cortex (DLPFC) is primarily
associated with:
A. Higher-level cognitive functioning and executive function
B. Motor inhibition
C. Speech production
D. Emotional processing
A. Higher-level cognitive functioning and executive function
RATIONALE: The dorsolateral prefrontal cortex (DLPFC) is
concerned with higher-level functioning, including working memory,
attention, and executive function. The ventrolateral prefrontal cortex
(VLPFC) is involved with motor inhibition.
5. The orbitofrontal cortex (OFC) is involved in which functions?
A. Decision-making and social behavior with a focus on punishment and
rewards
, B. Speech production and comprehension
C. Motor coordination
D. Fear and anxiety processing
A. Decision-making and social behavior with a focus on punishment
and rewards
RATIONALE: The OFC is involved in decision-making and social
behavior with a focus on punishment and rewards. Behaviors associated
with the OFC include sex, sugar, pain, social humiliation, money,
rewards, fame, and aggression.
6. Which brain region is most consistently associated with reduced
volume and activity in patients with major depressive disorder?
A. Amygdala
B. Prefrontal cortex
C. Hippocampus
D. Basal ganglia
C. Hippocampus
RATIONALE: The hippocampus shows consistent reductions in
volume and activity in major depressive disorder, likely due to chronic
stress-induced neurotoxicity mediated by elevated cortisol levels. This
is associated with memory impairments and cognitive dysfunction in
depression.
7. A current hypothesis for the cause of schizophrenia proposes that
N-methyl-D-aspartate (NMDA) receptors may be which of the
following?
A. Hypofunctional
B. Hyperfunctional
C. Completely absent
D. Overexpressed in the prefrontal cortex
A. Hypofunctional
